By Jo CavalloDecember 10, 2019 In 2018, researchers from Dana-Farber Cancer Institute launched a large, ambitious screening study called (PROMISE; ClinicalTrials.gov identifier NCT03689595) to identify people with premalignant precursor conditions of multiple myeloma, to understand the molecular signs of…
Investigators have assessed whether patients with certain chronic conditions may face delays in being diagnosed with lung cancer.
In a long-term follow-up of Women’s Health Initiative randomized trials, researchers identified risks of ovarian and endometrial cancers associated with the use of menopausal hormone…
A recent cohort study analyzed survival outcomes with immune checkpoint inhibitor treatment used in first- or second-line therapy, with treatment continuation vs discontinuation, and with…
False-positive recalls for additional imaging or biopsy may impact patients’ decisions to return for subsequent screening mammography, according to findings from a large, multicenter cohort…
An AI tool called DeepGEM may provide an advancement in genomic testing that offers an accurate, cost-effective, and timely method for gene mutation prediction from…
Patients with early-onset colorectal cancer living in rural vs urban areas were found to have a lower likelihood of 5-year survival, with persistent poverty compounding…
The antibody-drug conjugate ifinatamab deruxtecan (I-DXd) showed clinically meaningful responses in pretreated patients with extensive-stage small cell lung cancer (SCLC) in an interim analysis of…
An analysis from the phase III EORTC 1325-MG/KEYNOTE-054 trial found that adjuvant pembrolizumab was not associated with significant differences in long-term health-related quality of life…
The FDA has approved a new presentation of bortezomib (Boruzu) for ready-to-use subcutaneous or intravenous administration. This proteasome inhibitor is used for the treatment of…
In patients with hormone receptor–positive metastatic breast cancers with HER2-low or HER2-ultralow expression, treatment with the antibody-drug conjugate T-DXd was found to be superior to…
